Amelioration of Glucose Control Mobilizes Circulating Pericyte Progenitor Cells in Type 2 Diabetic Patients with Microangiopathy

Table 1

Patients characteristics. 𝑃 values are shown for paired Student’s 𝑡-test or the chi-square test as appropriate. ACEi/ARB denotes angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.

Characteristic	Without microangiopathy	With microangiopathy	𝑃
Number	23	15	—
Age (years)	62.7±2.4	67.2±1.2	0.08
Sex male (%)	68.8	81.8	0.36
BMI (kg/m^2)	29.5±1.3	27.2±0.6	0.10
Waist (cm)	103.5±3.3	99.8±2.2	0.35
Baseline HbA1c (%)	9.0±0.3	8.6±0.2	0.19
Concomitant risk factors
Total cholesterol (mg/dL)	183.1±6.5	176.8±9.7	0.61
HDL cholesterol (mg/dL)	51.3±2.9	43.2±2.1	0.026
LDL cholesterol (mg/dL)	105.6±5.2	97.1±8.5	0.43
Triglycerides (mg/dL)	131.1±14.5	181.8±25.2	0.11
Smoking habit (%)	0.0	13.6	0.13
Hypertension (%)	93.8	81.8	0.29
Complications
Retinopathy (%)	0.0	45.5	<0.01
Microalbuminuria (%)	0.0	50.0	<0.01
Neuropathy (%)	0.0	40.9	<0.01
Peripheral arterial disease (%)	6.3	36.4	0.03
Coronary artery disease (%)	18.8	27.3	0.55
Cerebrovascular disease (%)	75.0	77.2	0.82
Medications
Metformin (%)	93.8	81.8	0.29
Sulphonylureas (%)	68.8	68.2	0.97
Aspirin (%)	68.8	86.3	0.19
Statin (%)	56.3	68.2	0.46
ACEi/ARBs (%)	87.5	63.6	0.10
Other antihypertensives (%)	68.8	63.6	0.75